Medicines appraisal cards

Medicines appraisal cards have been developed for the Guidelines audience to announce new recommendations from the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC), and the All Wales Medicines Strategy Group (AWMSG). Items may contain pharmaceutical promotional information.

Image of first page of NICE TA card

NICE Technology Appraisal 607: Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease

2019-10-24T10:32:00+01:00Commissioned by Bayer

The production of this Guidelines card has been commissioned by Bayer plc. Bayer plc has reviewed the card for technical accuracy and regulatory compliance and supplied the prescribing information.